Evan Cohen

Assistant Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Evan Cohen is an Assistant Professor at The University of Texas MD Anderson Cancer Center in the United States. His research primarily focuses on metastatic breast cancer, circulating tumor cells, and the molecular characteristics of various cancers, including high-grade B-cell lymphoma. Recent publications highlight his investigations into the clinicopathologic features of tumors and the implications of gene expression profiles in treatment responses.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (4)

Naoto Ueno

Professor of Medicine

University of Hawai'i Cancer Center

UNITED STATES

View details

Yu Shen

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Julie E. Lang

University of Southern California

UNITED STATES

View details

Bora Lim

Associate Professor

Baylor College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Evan Cohen

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy

Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients

The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified.

Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B-acute lymphoblastic leukemia/lymphoma.

Gene expression profiling of circulating tumor cells captured by MicroCavity Array is superior to enumeration in demonstrating therapy response in patients with newly diagnosed advanced and locally advanced non-small cell lung cancer.

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix<sup>®</sup> PC1 System

Ensemble of nucleic acid absolute quantitation modules for copy number variation detection and RNA profiling

EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.

Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated with an Immunosuppressive Tumor Microenvironment.

Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression.

Collaborators (4)

Naoto Ueno

Yu Shen

Julie E. Lang

Bora Lim

Make your next move.